No Data
No Data
MASSIVE Announced as Lien Resolution Administrator in Abbott Infant Formula Product Liability Litigation
Abbott Labs Is Maintained at Outperform by Evercore ISI Group
Evercore Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $124
Abbott, Reckitt Trial Over Infant Formula Safety Starts in Missouri: Report
Abbott Laboratories (ABT): 69 Hedge Fund Holders and Strong Wall Street Support
Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger